| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/30/2010 | EP2201117A2 Extracellular targets for alzheimer's disease |
| 06/30/2010 | EP2201040A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 06/30/2010 | EP2201037A1 The present invention relates to methods for prediction of the therapeutic success of breast cancer therapy |
| 06/30/2010 | EP2201035A1 Novel avian cytokines and genetic sequences encoding same |
| 06/30/2010 | EP2201026A1 Novel p2x7 epitopes |
| 06/30/2010 | EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 06/30/2010 | EP2200647A1 Antibodies specific for human hepcidin |
| 06/30/2010 | EP2200634A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 06/30/2010 | EP1581559B1 VL DAb FC FUSION |
| 06/30/2010 | EP1578799B1 Antibodies directed to tumor necrosis factor and uses thereof |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1390535B1 Combinatorial libraries of monomer domains |
| 06/30/2010 | CN101762704A Monoclonal antibody preparation method and application thereof |
| 06/30/2010 | CN101759804A Anti-human thyroglobulin monoclonal antibody and application thereof |
| 06/30/2010 | CN101759800A Preparation of dirhamnolipid artificial antigen and antibody, enzyme-linked immunity test paper, preparation and detection method thereof |
| 06/30/2010 | CN101759781A Protein adhered to surface layers of bacteria and application thereof |
| 06/30/2010 | CN101200720B Mitochondrial membrane potential decrease related polynucleotide as well as coded polypeptide and uses thereof |
| 06/29/2010 | US7745699 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits |
| 06/29/2010 | US7745589 Antibodies and unnatural substrates of prenylation enzymes for use in detecting and isolating prenylated proteins |
| 06/29/2010 | US7745588 Antibodies to a paralytic peptide |
| 06/29/2010 | US7745587 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 06/29/2010 | US7745585 humanized, chimeric, genetic engineered, monoclonal or polyclonal antibody, or fragment, useful in the therapy of cancer, fibrosis and chronic obstructive pulmonary disease |
| 06/29/2010 | US7745583 monoclonal antibodies comprising a light chain variable and a heavy chain variable regions, having complementary determining regions, useful for increasing muscle mass and bone density |
| 06/29/2010 | US7745582 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis |
| 06/29/2010 | US7745580 polypeptide comprising an amino acid sequence that comprises lymphoctye epitopes and is capable of inducing an immune response against a molecule expressed on the surface of an intact erythrocyte infected by a placental parasite; vaccines |
| 06/29/2010 | US7745579 Inhibitor of NF-KB activation |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |
| 06/29/2010 | US7745576 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 06/29/2010 | US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 06/29/2010 | US7745403 Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues |
| 06/29/2010 | US7745397 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 06/29/2010 | US7745394 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 06/29/2010 | US7745230 Estrogen receptors and methods of use |
| 06/29/2010 | US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/29/2010 | US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein |
| 06/29/2010 | US7745159 Using presence and concentration of mesothelin related antigen (MRA) to detect and prognose tumors; antitumor agents |
| 06/29/2010 | US7745151 Methods of determining binding between Nogo receptor and p75 neurotrophin receptor |
| 06/29/2010 | US7745139 for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension |
| 06/29/2010 | US7745108 Method for identifying terpene synthase |
| 06/29/2010 | US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 06/29/2010 | US7744897 Human immunodeficiency virus gp41 mimetibody polypeptides |
| 06/29/2010 | US7744894 Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24 |
| 06/29/2010 | US7744891 Using lymphotoxin-beta receptors ligand specific immunoglobulin as therapeutic agent in treatment and prevention of lupus and thrombocytopenia |
| 06/29/2010 | US7744890 reducing the concentration of salts such as sodium chloride, in an antibody preparation to reduce the opalescent appearance of the preparation and/or the formation of high molecular weight proteins in the preparation |
| 06/29/2010 | US7744888 Controlling immunology response; autoimmune disease, antiallergens |
| 06/29/2010 | US7744887 Human scFvs which interact with a conformational epitope along the pre-hairpin, N-helix coiled coil structure within the heptad repeat 1 (HR1) region of gp41 of HIV; reducing viral load levels within an infected individual |
| 06/29/2010 | US7744886 Methods for interfering with rank signaling |
| 06/29/2010 | US7744885 administering antibodies or antigen-binding fragments which are specific for human tumor necrosis factor- alpha (TNF alpha), used for in vivo medical diagnosis and therapy; immunoassay and immunotherapy |
| 06/29/2010 | US7744884 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders |
| 06/29/2010 | US7744882 Human estrogen specific immunoglobulin for use as evaluative tool in diagnosing/prognosing metastatic cancers; evaluating efficacy of anticancer treatment |
| 06/29/2010 | US7744881 for cancer treatment by inducing apoptosis; monoclonal antibodies; drug conjugated with polyoxyethylene glycol or enzyme or radioisotope, fluorescent compound or chemiluminescent compound; genetic engineering; biodrugs; anticarcinogenic agents |
| 06/29/2010 | US7744880 cell proliferation-inhibiting activity by ADCC (antibody-dependent cell-mediated cytotoxicity) activity and CDC (complement-dependent cytotoxicity); hepatic cancer |
| 06/29/2010 | US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof |
| 06/29/2010 | US7744877 Administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies for treating B cell lymphoma |
| 06/29/2010 | US7744876 A soluble immunoglobulin-polypeptide chimera comprising an immunoglobulin having a complementarity determining region 3 (CDR3); endocytic presentation of an immunosuppressive factor for the down regulation of diabetogenic T cells for the treatment of type 1 diabetes |
| 06/29/2010 | US7744875 Administering antibodies, CD antigens in a dosage sufficient to induce a breakthrough event that can be detectable such as diarrhea, enterocolitis, dermatitis, hypophysitis, panhypopituitarism, rash, pruritis, dermatitis, vitiligo, and enterocolitis; for cancer treatment |
| 06/29/2010 | US7744874 Anti-sclerostin antibodies |
| 06/29/2010 | US7744871 comprising an antibody against an EGF receptor and a vaccine which induces antibodies against EGF or TGF alpha; based on the blockade of receptors with protein kinase activity in tyrosine residues (Receptor Tyrosine Kinases, RTK) |
| 06/29/2010 | US7744866 IL-1β binding antibodies and binding fragments thereof |
| 06/29/2010 | US7744865 comprising heavy chain and light chain variable regions that binds to human interleukin-1 beta with a dissociation constant less than 1 pM; time-release and sustained-release drugs |
| 06/29/2010 | US7744863 inhibiting Th1 immune response of an anti-CD3 monoclonal antibody and IL-5; type I diabetes, multiple sclerosis, rheumatoid arthritis, psoriasis, glomerulonephritis, myasthenia gravis, chronic inflammatory demyelinating neuropathy and inflammatory bowel disease; autoimmune disease |
| 06/29/2010 | CA2482747C Vaccine composition for preventing meningococcal disease |
| 06/29/2010 | CA2398467C Antibody for detecting chlamydia pneumoniae |
| 06/29/2010 | CA2390082C Novel hcv non-structural polypeptide |
| 06/29/2010 | CA2360053C Plant gene |
| 06/29/2010 | CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/29/2010 | CA2252372C Pathogenic escherichia coli associated protein |
| 06/29/2010 | CA2187740C Dna encoding bradykinin b1 receptor |
| 06/29/2010 | CA2163976C Methods and compositions for inhibiting cd14 mediated cell activation |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010071237A1 Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent |
| 06/24/2010 | WO2010071208A1 Antibody purification method |
| 06/24/2010 | WO2010070346A2 BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Ra) - 836 |
| 06/24/2010 | WO2010070263A1 Non-human transgenic animals expressing humanised antibodies and use therof |
| 06/24/2010 | WO2010070134A1 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5 |
| 06/24/2010 | WO2010070094A1 Myostatin binding proteins |
| 06/24/2010 | WO2010069858A1 Pharmaceutical composition |
| 06/24/2010 | WO2010069765A1 ANTI-cMET ANTIBODY |
| 06/24/2010 | WO2010069603A1 Human anti-alpha-synuclein autoantibodies |
| 06/24/2010 | WO2010069532A1 Antibodies against human angiopoietin 2 |
| 06/24/2010 | WO2010069331A2 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
| 06/24/2010 | WO2010048192A3 Viral inactivation during purification of antibodies |
| 06/24/2010 | WO2010046592A3 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
| 06/24/2010 | WO2010037856A3 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 06/24/2010 | WO2010036031A3 Pauf-specific human monoclonal antibody, pharmaceutical composition for treating cancer comprising the same and method for detecting cancer using the same |
| 06/24/2010 | WO2010034514A9 Novel regulators of the innate immune system |
| 06/24/2010 | WO2010032059A3 Antibodies directed to cd105 and uses thereof |
| 06/24/2010 | WO2010030840A3 Novel receptor and uses thereof |
| 06/24/2010 | WO2010023482A3 Therapeutic antibody |
| 06/24/2010 | WO2010019952A3 Methods and systems for predicting response of cells to a therapeutic agent |
| 06/24/2010 | WO2010006772A3 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 06/24/2010 | WO2009158618A4 Avian reoviridae |
| 06/24/2010 | US20100162439 Pesticidal genes from brevibacillus and methods for their use |
| 06/24/2010 | US20100162437 Functional r-gene from solanum bulbocastanum |
| 06/24/2010 | US20100162433 Plants with improved nitrogen utilization and stress tolerance |
| 06/24/2010 | US20100162432 Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko |
| 06/24/2010 | US20100160611 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 06/24/2010 | US20100160420 Novel simian t-cell lymphotropic virus |
| 06/24/2010 | US20100160235 Fgf homologs compositions and uses thereof |